Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 10 November 2000:
Vol. 290. no. 5494, p. 1063
DOI: 10.1126/science.290.5494.1063
Prev | Table of Contents | Next

News of the Week

CLINICAL TRIALS:
Company, Researchers Battle Over Data Access

Carol Cruzan Morton

A dispute between university-based researchers and the corporation that funded their study is threatening to erupt into a $7 million to $10 million legal battle. Last week, the researchers reported that a large clinical trial of an immune system booster to treat HIV-infected people found that the drug isn't effective in slowing progression to AIDS or reducing mortality. The company that developed the drug tried to block publication of the study unless the researchers included the company's analysis of a subset of the data that suggests the drug might help some people. The researchers refused.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)